IM Cannabis Reports Q2 and H1 2026 Results With Deteriorating Liquidity
Aug 13, 2026, 5:07 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The company shows material cash constraints (CAD 1.6m) against CAD 30.3m liabilities, persistent losses (six-month net CAD 6.9m; Q2 net CAD 4.4m), and a shareholder deficit, all of which pressure valuation and may trigger dilution or debt actions. Similar micro-cap cannabis names with weak liquidity and negative cash flow have seen sharp, short-term price declines until liquidity or profitability improves (e.g., periods of 6–12 months of testing for carve-outs, cost-cutting, or refinancing). Expect potential negative reaction to any further burn or guidance that delays profitability milestones.
AI summary
What happened, with direct paths to the underlying reporting
IM Cannabis Corp. posted six-month 2026 revenue of CAD 16.3m and a CAD 6.9m net loss, with cash at CAD 1.6m and liabilities of CAD 30.3m. The results show ongoing top-line weakness and widening losses, highlighting liquidity risk and a tight runway absent meaningful improvement or financing. The company cites Israel and Germany operations and potential expansion into technology-driven sectors as longer-term growth avenues, but near-term profitability remains uncertain.
Six-month revenue CAD 16.3m, down from CAD 25.2m in 2025.
Net loss CAD 6.9m; cash CAD 1.6m; liabilities CAD 30.3m.
Shareholders’ deficit CAD 5.5m; notes available on SEDAR+ and EDGAR.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
IM Cannabis Corp. announced a Share Purchase Agreement to sell IMC Holdings and European assets to Slil, with a pre-closing reorganization that leaves Israeli operations with IMCC…
